Ever-changing landscape of biosimilars in Canada; findings and implications from a global perspective

Brian Godman, Eleonora Allocati, Evelien Moorkens

Research output: Contribution to journalEditorial

12 Downloads (Pure)

Abstract

Siu et al. have comprehensively assessed the rapidly changing regulation and reimbursement environment for biologicals and biosimilars in Canada and the resultant implications.
Original languageEnglish
Number of pages7
JournalGenerics and Biosimilars Initiative journal
Volume8
Issue number3
Early online date25 Sep 2019
Publication statusE-pub ahead of print - 25 Sep 2019

Keywords

  • biosimilars
  • Canada
  • reimbursement
  • health policies

Fingerprint Dive into the research topics of 'Ever-changing landscape of biosimilars in Canada; findings and implications from a global perspective'. Together they form a unique fingerprint.

Cite this